Patients (n= 10) | Control subjects (n= 10) | |||
---|---|---|---|---|
Before | After | Before | After | |
Sex (female/male) | 6/4 | - | 9/1 | - |
Age (years) | 72.6 ± 2.6 | - | 69.6 ± 1.2 | - |
Onset-to-study duration (range; months) | 8.7 ± 2.2 (2-20) | - | - | - |
BMI (kg/m2) | 23.6 ± 3.4 | - | 22.5 ± 0.9 | - |
Blood pressure (systolic/diastolic, mm Hg) | 160 ± 5/87 ± 4 | - | 148 ± 5/85 ± 3 | - |
Smokers (n) | 2 | - | 2 | - |
Hypertension (n) | 6 | - | 5 | - |
Hypercholesterolemia (n) | 3 | - | 2 | - |
ESR (mm/h) | 71.1 ± 8.4 | 56.6 ± 12.6a | 11.0 ± 3.1e | 9.4 ± 2.8e |
CRP (mg/dl) | 7.5 ± 1.9 | 3.5 ± 1.2b | 1.1 ± 0.1e | < 1.0e |
IL-6 (pg/ml) | 76.4 ± 31.3 | 22.1 ± 4.4c | 4.1 ± 1.6e | 4.7 ± 1.8e |
TNF-α (pg/ml) | 9.1 ± 1.6 | 16.9 ± 2.6d | 3.8 ± 0.5e | 16.4 ± 3.2d |